Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Regulatory News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
68.50    -2.00 (-2.84%)
Bid:
68.00
Ask:
69.00
Spread: 1.00 (1.471%)
Market Cap: £320.96m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Issue of Equity

20 Jan 2014 07:00

RNS Number : 0026Y
Avacta Group PLC
20 January 2014
 



 

 

 

 

 

Avacta Group plc

("Avacta" or the "Group")

 

Issue of Equity

 

Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, today announces that 3,529,411 Ordinary Shares of 0.1p ("new Ordinary Shares") have been issued by the Company pursuant to the exercise of share options by an employee.

 

Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 24 January 2014.

 

The total number of Ordinary Shares in issue following the above issue will be 4,022,551,956 each with voting rights. No Ordinary Shares are held in Treasury.

 

The above figure of 4,022,551,956 shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules.

 

 

- Ends -

 

Enquiries:

Avacta Group plc

Tel: +44 (0) 844 414 0452

Alastair Smith, Chief Executive Officer

www.avacta.com

Tim Sykes, Chief Financial Officer

Numis Securities Limited

Tel: +44 (0) 207 260 1000

Michael Meade / Freddie Barnfield - Nominated Adviser

www.numiscorp.com

James Black - Corporate Broking

Walbrook PR Ltd

Tel: +44 (0) 20 7933 8780 or avacta@walbrookpr.com

Paul McManus

Mob: +44 (0)7890 541 893

Lianne Cawthorne

Mob: +44 (0)7584 391 303

 

 

 

 

 

 

 

 

 

 

 

 

About Avacta Group plc - www.avacta.com

 

Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through three divisions:

 

Avacta Analytical

www.avactaanalytical.com

 

High throughput analysis instrument, Optim, to help reduce the cost and risk of drug development.

Avacta Animal Health

www.avactaanimalhealth.com

 

Veterinary diagnostics reference laboratory, diagnostic kits and newly launched in-clinic blood analyser, Sensipod.

Avacta Life Sciences

www.avactalifesciences.com

 

Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development.

 

Avacta joined AIM in August 2006 and is based in Wetherby, England.

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUWVNRSOAAAAR
Date   Source Headline
21st Oct 20097:00 amPRNPlacing and Issue of Equity
6th Oct 20097:00 amRNSOptim - Second Order
28th Sep 20097:00 amPRNRe Agreement
16th Sep 20093:03 pmRNSHolding(s) in Company
11th Sep 20094:26 pmRNSHolding(s) in Company
11th Sep 20093:59 pmRNSHolding(s) in Company
7th Aug 20097:00 amPRNPre-Close Trading Statement
28th Jul 20095:07 pmRNSHolding(s) in Company
13th Jul 20094:40 pmRNSDirector/PDMR Shareholding
10th Jul 20094:17 pmRNSIssue of Equity
9th Jul 20094:29 pmRNSFurther re Acquisition of Theragenetics Limited
23rd Apr 20097:00 amRNSHalf Yearly Report
23rd Apr 20097:00 amPRNOPTIM Product Launch
31st Mar 200912:20 pmPRNAnalyst Presentation
30th Mar 200912:59 pmPRNDirector/PDMR Shareholding
3rd Mar 20091:17 pmRNSCompletion of Acquisition of Curidium Medica plc
2nd Mar 200912:00 pmRNSResult of Court Hearing
12th Feb 20091:23 pmRNSRule 8.1- (Curidium Medica Plc)
11th Feb 20092:09 pmRNSResults of meetings
9th Feb 200912:39 pmRNSResult of EGM
9th Feb 20097:00 amPRNAcquisition
26th Jan 20097:00 amPRNResult of AGM
16th Jan 20097:00 amRNSOffer Update
15th Jan 20099:24 amPRNAcquisition of Theragenetics Limited
9th Jan 200910:12 amRNSAvacta Group plc Acquisition
9th Jan 20097:00 amPRNAcquisition(s)
8th Jan 20092:29 pmRNSDirector/PDMR Shareholding
7th Jan 20097:00 amRNSIssue of Equity
12th Dec 200812:06 pmRNSFinal Results
20th Nov 20084:14 pmRNSDirector/PDMR Shareholding
5th Nov 200812:42 pmRNSIssue of Equity
4th Nov 20087:00 amPRNFinal Results
13th Oct 20087:00 amPRNChange of Adviser
11th Sep 20087:00 amPRNProduct Launch
21st Aug 20087:00 amPRNTrading Statement
14th Aug 200811:03 amPRNProduct Development Partnership
28th Jul 20087:00 amPRNProduct Launch
23rd Jul 20082:54 pmPRNDirector/PDMR Shareholding
14th Apr 20087:00 amPRNHalf-yearly Report
4th Apr 20085:20 pmRNSDirector/PDMR Shareholding
31st Mar 20087:00 amRNSTotal Voting Rights
10th Mar 20083:12 pmRNSIssue of Equity
31st Jan 200811:36 amRNSTotal Voting Rights
7th Jan 200810:50 amPRNRe Agreement
31st Dec 20077:00 amPRNTotal Voting Rights
14th Dec 20073:30 pmPRNAcquisition(s)
14th Dec 20073:05 pmPRNAGM Statement
21st Nov 20077:01 amRNSNotice of AGM
14th Nov 20079:08 amPRNAcquisition
9th Nov 20074:59 pmPRNDirectorate Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.